comparemela.com

Page 2 - Imran Alibhai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oral STAT3 Inhibitor Designated Orphan Drug for Idiopathic Pulmonary Fibrosis

The FDA has granted Orphan Drug designation to TT-101 for the treatment of idiopathic pulmonary fibrosis.

Imran alibhaiDrug administrationOrphan drug

Tvardi Therapeutics receives ODD for lead product TTI-101 to treat HCC

Tvardi Therapeutics, a clinical-stage biopharmaceutical company, has announced receipt of orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for its lead product, TTI-101, to treat hepatocellular carcinoma (HCC).

Imran alibhaiOrphan drug designation

Oral STAT3 Inhibitor Granted Orphan Drug Status for Hepatocellular Carcinoma

The FDA has granted Orphan Drug designation to TTI-101 for the treatment of hepatocellular carcinoma.

Imran alibhaiDrug administrationOrphan drug

Tvardi Therapeutics Raises $74M in Series B Financing

Tvardi Therapeutics Raises $74M in Series B Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United statesImran alibhaiSporos bioventuresJamie mcnabLifesci communicationsTvardi therapeutics incTvardi therapeuticsSlate path capitalPalkon capitalArrowmark partnersTvardi boardஒன்றுபட்டது மாநிலங்களில்இம்ரான் அலிபாய்ஜேமி மக்ந்யாப்கற்பலகை பாதை மூலதனம்

Tvardi Therapeutics raises $74M Series B - Houston Business Journal

Tvardi Therapeutics raises $74M Series B - Houston Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United statesChris mathewsRonald depinhoImran alibhaiDavid tweardySporos bioventuresJamie mcnabJim allisonSporo strategic advisory councilHouston business journalTvardi therapeuticsSlate path capitalPalkon capitalArrowmark partnersHouston based sporosCancer center

vimarsana © 2020. All Rights Reserved.